MedPath

Sexual Functioning After Primary Treatment of Ovarian Cancer

Terminated
Conditions
Ovarian Cancer
Sexual Dysfunction
Interventions
Behavioral: questionnaires
Registration Number
NCT00596544
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to help us learn more about sexual problems after treatment for ovarian cancer. At this time, we do not know how many women have sexual problems after they are treated for ovarian cancer.

How common are sexual problems after treatment for ovarian cancer?

* What factors make women more likely to have sexual problems after treatment for ovarian cancer?

* What happens to sexual functioning over the first 12 months after treatment? ie.

Does it get better or worse?

• Does referral to a specialized sexual health clinic help?

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
18
Inclusion Criteria
  • Women with any stage of invasive epithelial ovarian cancer who have completed frontline therapy within the past 6 months
  • Women must have no clinical evidence of disease
  • At least 18 years of age
  • English speaking
  • Able to participate in the informed consent process
  • Women who present to Sexual Health Clinic for the first time and meet all other eligibility criteria are eligible. Their FSFI scores will be used to determine the primary endpoint of prevalence of sexual dysfunction. If they score over 26 on the FSFI, they may still elect to be followed at the SHC.
Read More
Exclusion Criteria
  • Active secondary cancer requiring cytotoxic chemotherapy at the time enrollment
  • Evidence of recurrent/persistent disease by elevated CA125, findings on imaging (CT, PET scan etc) or physical examination
  • Women with borderline (low malignant potential) ovarian cancers
  • Women who are already in active evaluation and/or follow-up at the Sexual Health Clinic
  • Women with a history of prior whole pelvic radiation
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1questionnairesFSFI score \<= 26
2questionnairesFSFI score \>26
Primary Outcome Measures
NameTimeMethod
To estimate the prevalence of sexual dysfunction, as measured by Female Sexual Functioning Index (FSFI) among women who have completed first-line treatment for ovarian cancer within the last 6 months and currently have no evidence of disease.conclusion of study
Secondary Outcome Measures
NameTimeMethod
To study the natural history of sexual functioning in women after primary treatment of ovarian cancer by using the FSFI at approximately 3, 6 and 12 months.conclusion of study

Trial Locations

Locations (1)

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath